1 – 10 of 19
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
ABCC3 is a novel target for the treatment of pancreatic cancer
(
- Contribution to journal › Article
- 2018
-
Mark
Radiosynthesis, biological evaluation and preliminary microPET study of 18F-labeled 5-resorcinolic triazolone derivative based on ganetespib targeting HSP90
(
- Contribution to journal › Article
- 2017
-
Mark
GATA3 targets semaphorin 3B in mammary epithelial cells to suppress breast cancer progression and metastasis
(
- Contribution to journal › Article
- 2016
-
Mark
Increasing the Net Negative Charge by Replacement of DOTA Chelator with DOTAGA Improves the Biodistribution of Radiolabeled Second-Generation Synthetic Affibody Molecules
(
- Contribution to journal › Article
- 2015
-
Mark
Integrated Transcriptomic and Glycomic Profiling of Glioma Stem Cell Xenografts
(
- Contribution to journal › Article
-
Mark
ESI-MS/MS and MALDI-IMS Localization Reveal Alterations in Phosphatidic Acid, Diacylglycerol, and DHA in Glioma Stem Cell Xenografts
(
- Contribution to journal › Article
- 2014
-
Mark
Gallium-68-labeled affibody molecule for PET imaging of PDGFRβ expression in vivo
(
- Contribution to journal › Article
-
Mark
188Re-ZHER2:V2, a promising affibody-based targeting agent against HER2-expressing tumors : preclinical assessment
2014) In Journal of nuclear medicine : official publication, Society of Nuclear Medicine 55(11). p.8-1842(
- Contribution to journal › Article
-
Mark
Incorporation of a triglutamyl spacer improves the biodistribution of synthetic affibody molecules radiofluorinated at the N-terminus via oxime formation with (18)F-4-fluorobenzaldehyde
(
- Contribution to journal › Article
- 2013
-
Mark
Stromal EGF and igf-I together modulate plasticity of disseminated triple-negative breast tumors
(
- Contribution to journal › Article